Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions

Clin Genet. 1989 Oct;36(4):219-28. doi: 10.1111/j.1399-0004.1989.tb03194.x.

Abstract

Hobbs et al. (N. Engl. J. Med. 317: 734-737, 1987) reported a large deletion of approximately 10 kilobases in the 5' portion of the human low-density lipoprotein (LDL) receptor gene. This deletion affects about 60% of familial hypercholesterolemia (FH) heterozygotes in the French Canadian population. We have developed a rapid, convenient method for the detection of the deletion using double digestion with the restriction enzymes XbaI and EcoRV, or triple digestion with XbaI, EcoRV and XmnI, and a 650 bp cDNA probe, radio-labeled using a random oligonucleotide primer technique. Eighty French Canadian FH heterozygotes were screened for the presence of the deletion. Forty-seven (59%) of them were found to carry the 10 kb deletion. Using the same method, we also identified a new mutation which was found in four of the 80 (5%) FH patients. This mutation has been found to be a 5 kb deletion removing exons 2 and 3 of the LDL receptor gene, which correspond to the first two repeats of the LDL receptor binding domain. Cosegregation of the 5 kb deletion and the FH phenotype was observed in one family. Possible structure-function relationship is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Canada
  • Chromosome Deletion*
  • DNA Probes
  • DNA Restriction-Modification Enzymes*
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / diagnosis
  • Hyperlipoproteinemia Type II / genetics*
  • Male
  • Mutation
  • Pedigree
  • Receptors, LDL / genetics*

Substances

  • DNA Probes
  • DNA Restriction-Modification Enzymes
  • Receptors, LDL